http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2238736-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16
filingDate 1996-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_844d9df44b3170c245ec0fd7965928c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c29c2264e5c3486660288c53648006b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42f933dd593c61961658a5bec534e9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aafa677040b0073028645eebe4e30469
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_207021c0e4f2ed1e991aee502c364ba5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e362bda60ea53f4f3a3d6b5a90e37d
publicationDate 1997-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2238736-A1
titleOfInvention Novel a1 adenosine receptor agonists and antagonists
abstract Adenosine and xanthine derivatives, and compositions comprising those compounds, are potent selective agonists and antagonists of adenosine receptors. The derivatives and compositions are used to treat conditions, including certain cardiac arrhythmias.
priorityDate 1995-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432787922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410918180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447916

Total number of triples: 37.